Medicxi Ventures Management (Jersey) Ltd

Medicxi Ventures Management (Jersey) Ltd latest Q4_2020 13F filings reported $172,068,000 in market value on this 2021-02-12 report date . The portfolio quarterly return is -17.83%. This fund has 5 securities concentrations of 100% weights.

Medicxi Ventures Management (Jersey) Ltd largest holding is Phathom Pharmaceuticals Inc. with weight of 39.92% and $68,694,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-122020-12-31Q4_202013F-HR5$172,068,000-17.83%
2020-10-272020-09-30Q3_202013F-HR5$209,408,00028.70%
2020-08-072020-06-30Q2_202013F-HR4$162,707,000112.59%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
PHATHOM PHARMACEUTICALS INCPHATDECR$68,694-0.09%39.92%$33.220.00%2,067,861
VAXCYTE INCPCVXDECR$50,150-0.46%29.15%$26.570.00%1,887,478
Merus N.V.MRUSINCR$28,0480.46%16.30%$17.530.00%1,600,000
CHECKMATE PHARMACEUTICALS INCMPIINCR$21,9100.27%12.73%$14.590.00%1,501,716
OBSEVA SAOBSVDECR$3,266-0.16%1.90%$2.080.00%1,570,000